CASP4 and chronic obstructive pulmonary disease: We found that the levels of the circulating caspase-4 in COPD patients was three times higher (95% CI, 1.703–2.995 ng/ml) than healthy subjects (Figure 3C), although these levels were still lower than those observed in lung cancer patients (Figure 3C).